Tag: new

FDA approves new standard of care for kidney cancer

The standard of care for kidney cancer patients continues to improve. The U.S. Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer. The results of the large, international clinical trial leading to the approval were just published the prestigious New England

New disease model to facilitate development of ALS and MS therapies

Researchers at Karolinska Institutet in Sweden have developed a new disease model for neurodegenerative diseases such as ALS and MS that can be used to develop new immunotherapies. The model is described in a publication in the scientific journal Nature Immunology. All of the body’s organs contain macrophages, which, as part of the immune system,

Team develops new way to fight HIV transmission

Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection. The tool, a vaginal implant, decreases the number of cells that the HIV virus can target in a woman’s genital tract. Unlike conventional methods of HIV prevention, such as condoms or anti-HIV drugs, the implant takes advantage of

Cancer protein could point to new targets for treatment

A new view of a protein frequently mutated in pituitary tumors is overturning conventional wisdom and could point to novel targets for cancer drugs. The protein, a “G protein” called Gαs, initiates messages inside cells. But a single mutation alters Gαs action in a surprising way. The protein’s molecular “off switch” actually switches activity on,

New study advocates for better information about PET/CT scanning

Improved information before undergoing PET/CT scanning can improve patients’ experience of care, demonstrates radiology nurse Camilla Andersson in a recent dissertation at Uppsala University. PET/CT scanning is increasingly common for various oncological matters, but it also requires care recipients to understand and follow instructions. Unprepared patients may entail delayed exams and postponed treatment, which can

New drug combo improves survival of women with rare uterine cancer

Adding the monoclonal antibody drug trastuzumab—already used to treat certain breast cancers—to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value.

Study sheds new light on how bilinguals process language

Research led by a psychologist at the University of California, Riverside, shows that bilinguals regulate, or suppress, their native language when reading in a second language. Many in media and in science often assume that reading or speaking in a second language—one that has been learned later in life than the native or first language—is

A potential new therapeutic target for Ewing sarcoma

The sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most frequent bone cancer in children and adolescents, and a tumor known for its aggressiveness and tendency to metastasize. The research is published in the International Journal

New point-of-care test quickly detects Lyme neuroborreliosis

A new research-based point-of-care test has been developed in Finland for detecting the Lyme neuroborreliosis spread by ticks. The test makes rapid initiation of antibiotic treatment possible for patients with borreliosis, which reduces the post-treatment symptoms related to the disease. At the same time, unnecessary antibiotic treatments can be avoided. The diagnosis of Lyme neuroborreliosis,

Cysticercosis epidemiology in Spain: What’s new?

Cysticercosis, an infection caused by larval cysts of a pork tapeworm, is a leading cause of seizures and epilepsy in many parts of the world. Now, researchers writing in PLOS Neglected Tropical Diseases have for the first time assessed the impact of cysticercosis hospitalizations in Spain. Cysticercosis is caused by larval cysts of the pork

New actors identified in atherosclerosis

Stroke and heart attack are the leading cause of death in the Western world. Würzburg scientists have used a special technique to get a clearer picture of the cells involved and their activity. Atherosclerosis is the most common cause of death and disease in the Western world. In Germany, about 300,000 people each year suffer

Immunotherapy—cancer’s new frontier

Your immune system never sleeps. Every moment of the day, immune cells monitor your body for disease, calling for backup when they detect a threat. It’s a system that works elegantly—most of the time. It’s not foolproof; if it were, we would never get cancer in the first place. “The immune system is supposed to

Here is how a cat can hinder children learning new words

Say you are shown an apple, a banana and a fruit you have never seen before. Then you are asked to pick the “pifo.” Which fruit would you choose? Chances are you would select the novel fruit. Children often use the same strategy—leveraging their knowledge of familiar objects—to learn new words and connect them with